Control of cell cycle progression in human mesothelioma cells treated with gamma interferon (Q40810908)

23 September 2017

title

Control of cell cycle progression in human mesothelioma cells treated with gamma interferon (English)

1 reference

23 September 2017

0 references

Vivo C

1

1 reference

23 September 2017

Lévy F

2

1 reference

23 September 2017

Pilatte Y

3

1 reference

23 September 2017

Fleury-Feith J

4

1 reference

23 September 2017

Chrétien P

5

1 reference

23 September 2017

Monnet I

6

1 reference

23 September 2017

Kheuang L

7

1 reference

23 September 2017

Jaurand MC

8

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

23 September 2017

number of pages

9

1 reference

inferred from page(s)

published in

Oncogene

1 reference

23 September 2017

volume

20

1 reference

23 September 2017

issue

9

1 reference

23 September 2017

page(s)

1085-1093

1 reference

Nuclear accumulation of interferon gamma

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Chemosensitivity and cytokine sensitivity of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

A novel DNA damage checkpoint involving post-transcriptional regulation of cyclin A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

CD40 ligation alters the cell cycle of differentiating keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Interferon-gamma suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Genetic toxicity of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Differential expression of the p27Kip1 mRNA in IFN-sensitive and resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

The European mesothelioma epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Transcriptional silencing of perlecan gene expression by interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Interferon-gamma-mediated inhibition of cyclin A gene transcription is independent of individual cis-acting elements in the cyclin A promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

A role for the cyclin-dependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Potential for Interferon-α-Based Therapy in Mesothelioma: Assessment in a Murine Model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Effect of interferon-alpha 2a on malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Cytometry of cyclin proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

How does interferon exert its cell growth inhibitory effect?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Chromosomal changes induced by chrysotile fibres or benzo-3,4-pyrene in rat pleural mesothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Proteolytic ratchets that control progression through mitosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Changes of cell cycle-regulating genes in interferon-treated Daudi cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204199

1 reference

Dimensions Publication ID

23 September 2017

1000384801

0 references

1 reference